Nesoddtangen, Norway

Ståle Petter Lyngstadaas

This inventor holds 7 USPTO granted patents and 4 published patent applications and 5 EPO patents. Top assignees: Biora Bioex Ab, Corticalis as, Biora Ab. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ståle Petter Lyngstadaas. Retrieved from https://idiyas.com/inventor/stale-petter-lyngstadaas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 57.1

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2005-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Ståle Petter Lyngstadaas: Innovator in Medical and Dental Implants

Introduction

Ståle Petter Lyngstadaas is a notable inventor based in Nesoddtangen, Norway. He has made significant contributions to the fields of medical and dental implants, holding a total of 7 patents. His innovative work focuses on enhancing osseointegration and dentin regeneration, which are crucial for successful medical and dental procedures.

Latest Patents

One of his latest patents is an "Implant modified with non-hydroxylated vitamin D precursors." This invention involves a medical or dental implant that features a metallic or polymeric base covered with the vitamin D precursor cholecalciferol. The implant can be created by directly covering the base with a solution containing cholecalciferol or by using 7-dehydrocholesterol (7-DHC) followed by UV irradiation to induce cholecalciferol formation. This innovative implant aims to enhance osseointegration in patients with compromised conditions by promoting the endogenous synthesis and activity of vitamin D in hard and mineralized tissue regeneration.

Another significant patent is related to "Matrix protein composition for dentin regeneration." This invention reveals that enamel matrix, enamel matrix derivatives, and/or enamel matrix proteins can induce dentin regeneration. The patent outlines the use of an active enamel substance in pharmaceutical compositions aimed at forming or regenerating dentin after dental procedures that expose vital dental pulp tissue. The method involves applying an effective amount of this active enamel substance to the exposed tissue post-procedure.

Career Highlights

Ståle Petter Lyngstadaas has worked with several companies, including Biora Bioex AB and Biora AB. His experience in these organizations has contributed to his expertise in the development of innovative dental and medical solutions.

Collaborations

He has collaborated with notable professionals in his field, including Stina Gestrelius and Marta Monjo. These partnerships have likely enriched his research and development efforts, leading to groundbreaking inventions.

Conclusion

Ståle Petter Lyngstadaas is a distinguished inventor whose work in medical and dental implants has the potential to significantly improve patient outcomes. His innovative patents reflect a commitment to advancing healthcare technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…